O'Reilly, Eileen

Publications

Sort by

Co-Author Network

selected publications

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. 2020 Academic Article GET IT
Times cited: 779
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI study. Cancer medicine. 2020 Academic Article GET IT
Times cited: 22
A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma. The oncologist. 2020 Academic Article GET IT
Times cited: 21
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Academic Article GET IT
Times cited: 146
Reply to N. Fazio. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Letter GET IT
Times cited: 1
An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review. JAMA oncology. 2020 Review GET IT
Times cited: 12
Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Editorial Article GET IT
Times cited: 24
Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings. Cancer. 2020 Academic Article GET IT
Times cited: 33
Author Correction: Tumour lineage shapes BRCA-mediated phenotypes. 2020 GET IT
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial. JAMA oncology. 2019 Academic Article GET IT
Times cited: 82
A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer. Cancer medicine. 2019 Academic Article GET IT
Times cited: 68
Tumour lineage shapes BRCA-mediated phenotypes. Nature. 2019 Academic Article GET IT
Times cited: 291
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer. The New England journal of medicine. 2019 Academic Article GET IT
Times cited: 246
Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Academic Article GET IT
Times cited: 49
Binimetinib plus Gemcitabine and Cisplatin Phase I/II Trial in Patients with Advanced Biliary Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 28
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Academic Article GET IT
Times cited: 420
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms. Journal of the National Cancer Institute. 2018 Academic Article GET IT
Times cited: 183
Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior. BMC cancer. 2018 Academic Article GET IT
Times cited: 38
A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies. Cancer chemotherapy and pharmacology. 2018 Academic Article GET IT
Times cited: 35
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience. BMC cancer. 2018 Academic Article GET IT
Times cited: 73
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 390
Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Academic Article GET IT
Times cited: 209
A Randomized Trial of Acceptability and Effects of Values-Based Advance Care Planning in Outpatient Oncology: Person-Centered Oncologic Care and Choices. Journal of pain and symptom management. 2018 Academic Article GET IT
Times cited: 26
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies. Investigational new drugs. 2018 Academic Article GET IT
Times cited: 82
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease. The Lancet. Oncology. 2018 Guideline GET IT
Times cited: 54
Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?. Clinical colorectal cancer. 2018 Academic Article GET IT
Times cited: 13
Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma. Clinical colorectal cancer. 2018 Academic Article GET IT
Times cited: 16
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 279
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma. Cancer. 2018 Academic Article GET IT
Times cited: 94
Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2018 Academic Article GET IT
Times cited: 16
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma. European journal of cancer. 2017 Academic Article GET IT
Times cited: 125
Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients. PloS one. 2017 Academic Article GET IT
Times cited: 67
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results. The oncologist. 2017 Academic Article GET IT
Times cited: 34
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing. JAMA. 2017 Academic Article GET IT
Times cited: 369
Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies. Cancer treatment reviews. 2017 Information Resource GET IT
Times cited: 79
A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma. Cancer. 2017 Academic Article GET IT
Times cited: 33
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
Times cited: 80
An elderly man with remote history of metastatic melanoma now with localized pancreas cancer and new liver masses. 2017 GET IT
Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer. British journal of cancer. 2017 Academic Article GET IT
Times cited: 68
Management of Metastatic Pancreatic Adenocarcinoma. The Surgical clinics of North America. 2016 Information Resource GET IT
Times cited: 7
Current management and future directions in metastatic pancreatic adenocarcinoma. Cancer. 2016 Review GET IT
Times cited: 21
Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer. Cell reports. 2016 Academic Article GET IT
Times cited: 78
Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer. Pancreas. 2016 Academic Article GET IT
Times cited: 51
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Guideline GET IT
Times cited: 254
Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer. Practical radiation oncology. 2016 Academic Article GET IT
Times cited: 18
Discussions of Life Expectancy and Changes in Illness Understanding in Patients With Advanced Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 181
Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications. Clinical colorectal cancer. 2016 Academic Article GET IT
Times cited: 38
Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches. Expert review of gastroenterology & hepatology. 2016 Review GET IT
Times cited: 46
Adjuvant and Neoadjuvant Therapy for Pancreatic Cancer. Surgical oncology clinics of North America. 2016 Information Resource GET IT
Times cited: 17
Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Times cited: 265
Identification of germline genetic mutations in patients with pancreatic cancer. Cancer. 2015 Academic Article GET IT
Times cited: 172
Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy. Expert opinion on therapeutic targets. 2015 Information Resource GET IT
Times cited: 31
"This is not me": patient, family, cultural and clinician considerations in cases of severe cancer-related debility. Journal of gastrointestinal oncology. 2015 Academic Article GET IT
Liver resection for metastatic colorectal leiomyosarcoma: a single center experience. Journal of gastrointestinal oncology. 2015 Academic Article GET IT
Times cited: 15
Intensity modulated radiation therapy reduces gastrointestinal toxicity in locally advanced pancreas cancer. Practical radiation oncology. 2015 Academic Article GET IT
Times cited: 31
Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine. Gastroenterology. 2015 Review GET IT
Times cited: 88
Gemcitabine-Related Pneumonitis in Pancreas Adenocarcinoma--An Infrequent Event: Elucidation of Risk Factors and Management Implications. Clinical colorectal cancer. 2015 Academic Article GET IT
Times cited: 10
Intrahepatic cholangiocarcinoma: expert consensus statement. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2015 Academic Article GET IT
Times cited: 386
Novel Therapeutics for Pancreatic Adenocarcinoma. Hematology/oncology clinics of North America. 2015 Information Resource GET IT
Times cited: 9
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. European journal of cancer. 2015 Academic Article GET IT
Times cited: 15
FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma. Annals of surgical oncology. 2015 Academic Article GET IT
Times cited: 131
Liver-directed conversion therapy in metastatic colon cancer. Journal of gastrointestinal oncology. 2015 Academic Article GET IT
Times cited: 2
Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma. Clinical colorectal cancer. 2015 Academic Article GET IT
Times cited: 20
EBV-associated lymphoepithelioma-like carcinoma of the pancreas: Case report with targeted sequencing analysis. 2015 GET IT
Times cited: 11
'We have to discuss it': cancer patients' advance care planning impressions following educational information about cardiopulmonary resuscitation. Psycho-oncology. 2015 Academic Article GET IT
Times cited: 34
Novel directions in neoadjuvant therapy for pancreas adenocarcinoma. Expert review of gastroenterology & hepatology. 2015 Review GET IT
Times cited: 4
Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Times cited: 236
Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2015 Academic Article GET IT
Times cited: 85
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer. 2014 Academic Article GET IT
Times cited: 407
Adjuvant and neoadjuvant systemic therapy for pancreas adenocarcinoma. Seminars in oncology. 2014 Information Resource GET IT
Times cited: 12
DNA mismatch repair abnormalities in acinar cell carcinoma of the pancreas: frequency and clinical significance. Pancreas. 2014 Academic Article GET IT
Times cited: 28
Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 51
25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). Journal of the National Cancer Institute. 2014 Academic Article GET IT
Times cited: 32
A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2014 Academic Article GET IT
Times cited: 19
Lymph node ratio is an independent prognostic factor after resection of periampullary malignancies: data from a tertiary referral center in the middle East. American journal of clinical oncology. 2014 Academic Article GET IT
Times cited: 13
A woman with metastatic pancreatic neuroendocrine tumor. Gastrointestinal cancer research : GCR. 2014 Academic Article GET IT
Treatment of metastatic pancreatic adenocarcinoma: new options and promising strategies. Oncology (Williston Park, N.Y.). 2014 Comment GET IT
Times cited: 1
A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma. Journal of hepatology. 2013 Academic Article GET IT
Times cited: 83
c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival. Anticancer research. 2013 Academic Article GET IT
Times cited: 13
A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas. British journal of cancer. 2013 Academic Article GET IT
Times cited: 107
Postoperative outcomes following pancreaticoduodenectomy: how should age affect clinical practice?. World journal of surgical oncology. 2013 Academic Article GET IT
Times cited: 20
Optimal chemotherapy dosing in a bilateral lower extremities amputee with metastatic pancreatic adenocarcinoma. 2013 GET IT
A randomized controlled trial of a cardiopulmonary resuscitation video in advance care planning for progressive pancreas and hepatobiliary cancer patients. Journal of palliative medicine. 2013 Academic Article GET IT
Times cited: 75
Evolving panorama of treatment for metastatic pancreas adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Editorial Article GET IT
Times cited: 5
Prognosis of minimally invasive carcinoma arising in mucinous cystic neoplasms of the pancreas. The American journal of surgical pathology. 2013 Academic Article GET IT
Times cited: 36
Sunitinib malate for the treatment of pancreas malignancies--where does it fit?. Expert opinion on pharmacotherapy. 2013 Review GET IT
Times cited: 10
Management of a patient diagnosed with pancreatic cancer and myelodysplastic syndrome. Gastrointestinal cancer research : GCR. 2013 Academic Article GET IT
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2013 Academic Article GET IT
Times cited: 30
A young woman with liver cancer. Gastrointestinal cancer research : GCR. 2013 Academic Article GET IT
Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. Gastrointestinal cancer research : GCR. 2013 Academic Article GET IT
Targeted agents and systemic therapy in hepatocellular carcinoma. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 2013 Review GET IT
Times cited: 21
A Nonrandomized, Phase II Study of Sequential Irinotecan and Flavopiridol in Patients With Advanced Hepatocellular Carcinoma. Gastrointestinal cancer research : GCR. 2012 Academic Article GET IT
Management of a locally advanced rectal cancer in a patient who declined surgery. Gastrointestinal cancer research : GCR. 2012 Academic Article GET IT
Postresection surveillance for pancreatic cancer performance status, imaging, and serum markers. Cancer journal (Sudbury, Mass.). 2012 Information Resource GET IT
Times cited: 14
Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma. Gastrointestinal cancer research : GCR. 2012 Academic Article GET IT
A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers. PloS one. 2012 Academic Article GET IT
Times cited: 107
Communication and palliative care in a 64-year-old man with pancreatic adenocarcinoma. Gastrointestinal cancer research : GCR. 2012 Academic Article GET IT
Exocrine pancreas cancer and thromboembolic events: a systematic literature review. Journal of the National Comprehensive Cancer Network : JNCCN. 2012 Review GET IT
Times cited: 15
A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management. 2012 GET IT
Times cited: 1
A 72-year-old man with duodenal adenocarcinoma. Gastrointestinal cancer research : GCR. 2012 Academic Article GET IT
Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature. Human pathology. 2012 Review GET IT
Times cited: 68
Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasis. Diseases of the colon and rectum. 2012 Academic Article GET IT
Times cited: 16
Costs and trends in pancreatic cancer treatment. Cancer. 2012 Academic Article GET IT
Times cited: 87
A case of advanced gastric cancer. 2012 GET IT
A case of synchronous pancreatic ductal adenocarcinoma and ovarian mucinous cystic neoplasm: use of kras mutation molecular phenotyping to demonstrate independent primary origin. 2012 GET IT
Gastrointestinal cancer educatinal case series: a 65 year-old female with locally advanced gastric cancer and a supraclavicular lymph node. 2012 GET IT
Augmenting advance care planning in poor prognosis cancer with a video decision aid: a preintervention-postintervention study. Cancer. 2012 Academic Article GET IT
Times cited: 72
A 71-year-old man with a large cystic pancreatic mass. 2012 GET IT
Genomics and pharmacogenomics of pancreatic adenocarcinoma. The pharmacogenomics journal. 2011 Review GET IT
Times cited: 12
A woman with remotely treated pancreas cancer and new abdominal pain: a discussion of evaluation and management. 2011 GET IT
Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Annals of surgical oncology. 2011 Academic Article GET IT
Times cited: 48
Pancreatic cancer: the role of molecular markers in diagnosis and management. Clinical advances in hematology & oncology : H&O. 2011 Review GET IT
Times cited: 8
Targeting thrombosis in exocrine pancreas cancer: a continued need for improved therapies. Expert review of anticancer therapy. 2011 Editorial Article GET IT
Building on Individual, State, and Federal Initiatives for Advance Care Planning, an Integral Component of Palliative and End-of-Life Cancer Care. Journal of oncology practice. 2011 Academic Article GET IT
Times cited: 14
MicroRNA, hypoxic stress and hepatocellular carcinoma: future directions. Journal of gastroenterology and hepatology. 2011 Editorial Article GET IT
Times cited: 1
Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy. The oncologist. 2011 Academic Article GET IT
Times cited: 113
Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer. Cancer. 2011 Academic Article GET IT
Times cited: 60
An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions. The oncologist. 2011 Academic Article GET IT
Times cited: 221
A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma. 2011 GET IT
Times cited: 11
Gastrointestinal cancer educational case series: management of metastatic adenocarcinoma of unknown primary origin in a Ph+ ALL survivor. 2011 GET IT
Times cited: 1
Hepatocellular carcinoma following renal transplantation. Gastrointestinal cancer research : GCR. 2011 Academic Article GET IT
Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review. 2011 GET IT
Times cited: 17
New approaches to the treatment of pancreatic cancer: from tumor-directed therapy to immunotherapy. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 2011 Academic Article GET IT
Times cited: 5
Electronic Chemotherapy Order Entry: A Major Cancer Center's Implementation. Journal of oncology practice. 2011 Academic Article GET IT
Times cited: 16
Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303). Cancer. 2011 Academic Article GET IT
Times cited: 16
Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccine. American journal of clinical oncology. 2011 Academic Article GET IT
Times cited: 66
Synchronous epithelial and neuroendocrine cancers of the pancreas: case series of a rare occurrence. 2011 GET IT
Times cited: 1
Studying cancer in minorities: a look at the numbers. Cancer. 2011 Academic Article GET IT
Times cited: 4
A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603). The oncologist. 2010 Academic Article GET IT
Times cited: 64
Pancreatic adenocarcinoma: new approaches to a challenging malignancy. Oncology (Williston Park, N.Y.). 2010 Comment GET IT
Times cited: 2
Allergies, obesity, other risk factors and survival from pancreatic cancer. International journal of cancer. 2010 Academic Article GET IT
Times cited: 56
Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Annals of oncology : official journal of the European Society for Medical Oncology. 2010 Academic Article GET IT
Times cited: 85
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 759
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 19
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 580
Hepatocellular carcinoma in two patients with cardiac cirrhosis. 2010 GET IT
Times cited: 60
Advanced hepatocellular carcinoma: which staging systems best predict prognosis?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 282
Pancreatic islet cell carcinoma presenting with concurrent Cushing's and Zollinger-Ellison syndromes: case series and literature review. European journal of gastroenterology & hepatology. 2010 Review GET IT
Times cited: 6
Lack of splenic uptake of In-111 pentetreotide due to splenic embolization. 2009 GET IT
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Conference Paper GET IT
Times cited: 212
Targeted therapies for pancreatic adenocarcinoma. Minerva chirurgica. 2009 Review GET IT
Times cited: 3
Capsule-induced small-bowel obstruction during video capsule endoscopy in a patient with carcinomatosis. 2009 GET IT
Times cited: 1
Pancreatic adenocarcinoma in a young patient population--12-year experience at Memorial Sloan Kettering Cancer Center. Journal of surgical oncology. 2009 Academic Article GET IT
Times cited: 26
A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2009 Academic Article GET IT
Times cited: 40
Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer. Cancer gene therapy. 2009 Academic Article GET IT
Times cited: 38
Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors. Cancer investigation. 2009 Academic Article GET IT
Times cited: 1
Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Annals of surgical oncology. 2009 Conference Paper GET IT
Times cited: 199
Indications for neoadjuvant, adjuvant, and palliative chemotherapy in the treatment of biliary tract cancers. Surgical oncology clinics of North America. 2009 Review GET IT
Times cited: 3
The cost of staying well. Trustee : the journal for hospital governing boards. 2009 Academic Article GET IT
Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). Journal of surgical oncology. 2008 Academic Article GET IT
Times cited: 227
Collision tumor of the large bowel in the context of advanced pregnancy and ulcerative colitis. 2008 GET IT
Times cited: 10
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer. Investigational new drugs. 2008 Academic Article GET IT
Times cited: 4
A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 55
Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. The American journal of surgical pathology. 2008 Academic Article GET IT
Times cited: 199
What is the optimal treatment of localized pancreatic adenocarcinoma?. Oncology (Williston Park, N.Y.). 2008 Review GET IT
Times cited: 3
Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Annals of surgery. 2008 Academic Article GET IT
Times cited: 540
Sarbanes-Oxley on the not-for-profit horizon. Trustee : the journal for hospital governing boards. 2008 Academic Article GET IT
Pathologic complete response to neoadjuvant FOLFOX in combination with bevacizumab in unresectable metastatic colorectal carcinoma. 2008 GET IT
Times cited: 7
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer. Cancer chemotherapy and pharmacology. 2008 Academic Article GET IT
Times cited: 37
Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 74
A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Academic Article GET IT
Times cited: 73
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 393
Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 246
A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers. American journal of clinical oncology. 2005 Academic Article GET IT
Times cited: 10
Phase I and pharmacokinetic study of LY293111, an orally bioavailable LTB4 receptor antagonist, in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 23
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 95
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 105
Biliary tract cancers: current concepts and controversies. Expert opinion on pharmacotherapy. 2005 Review GET IT
Times cited: 25
Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 88
Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature. American journal of clinical oncology. 2003 Review GET IT
Times cited: 26
Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancer. Cancer investigation. 2003 Academic Article GET IT
Times cited: 19
Pancreatic cancer: epidemiology, genetics, and approaches to screening. Oncology (Williston Park, N.Y.). 2002 Review GET IT
Times cited: 21
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Annals of surgical oncology. 2002 Academic Article GET IT
Times cited: 55
A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan. Annals of oncology : official journal of the European Society for Medical Oncology. 2002 Academic Article GET IT
Times cited: 85
Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 144
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Annals of surgical oncology. 2001 Academic Article GET IT
Times cited: 104
A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2001 Academic Article GET IT
Times cited: 40
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 195
A phase II study of irinotecan in patients with advanced hepatocellular carcinoma. Cancer. 2001 Academic Article GET IT
Times cited: 71
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999 Academic Article GET IT
Times cited: 315
5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma. 1999 GET IT
Times cited: 76
Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 250
A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesothelioma. Cancer investigation. 1999 Academic Article GET IT
Times cited: 25
Irinotecan and cisplatin in upper gastrointestinal malignancies. Oncology (Williston Park, N.Y.). 1998 Review GET IT
Times cited: 18
Non-Hodgkin lymphoma as a cause of intrahepatic periportal low attenuation on CT. 1997 GET IT
Times cited: 20
Second cancers complicating Hodgkin's disease. 1996 GET IT
Times cited: 2
The medical treatment of advanced prostate cancer. Irish medical journal. 1994 Editorial Article GET IT

more ...

less ...

Background

education and training

M.B.,B.Ch., B.A.O., University of Dublin, Trinity College Faculty of Medicine (Ireland) 1990

Contact

full name

Eileen O'Reilly

VIVO Weill Cornell Medical College

Eileen O'Reilly Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name